| Literature DB >> 28537898 |
Dan Zhang1, Yang Zhang1, Baoyu Zhu1, He Zhang1, Ye Sun1, Chengxun Sun1.
Abstract
High-voltage electricity lines are known to generate extremely low-frequency electromagnetic fields (ELF-EMFs). With the process of urbanization, increasing concerns has been focused on the potentially hazardous impacts of ELF-EMF on human health, and the conclusions are controversial. Little is known about the method of prevention against ELF-EMF induced healthy problems. A total of 186 male workers with occupational exposure to high-voltage electricity lines, and 154 male subjects with insignificant exposure as reference control were enrolled in this study. Resveratrol or placebo was given as dietary supplements (500 mg twice daily), and several inflammatory biomarkers and biomarkers of oxidative stress were assessed. Workers who had long-term exposure to high-voltage electricity lines exhibited elevated urinary levels of 8-hydroxy-2-deoxy-guanosine (8-OHdG) and F2-isoprostane, compared to the reference group. Lower plasma nuclear factor kappa B (NF-κB) and interleukin (IL)-6 were observed in exposed workers compared to the reference group. Resveratrol significantly reversed the adverse impacts of ELF-EMF. Stimulated cytokine production by resveratrol was found in exposed workers but not in the reference group. This study supported that occupational and long-term exposure to high-voltage electricity lines has an adverse effect on homeostasis of human body, and resveratrol supplement could be an effective protection strategy against the adverse effects induced by ELF-EMFs.Entities:
Keywords: ELF-EMFs; biomarkers of oxidative stress; high-voltage electricity lines; inflammatory; resveratrol
Mesh:
Substances:
Year: 2017 PMID: 28537898 PMCID: PMC5564581 DOI: 10.18632/oncotarget.17668
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Inclusion and exclusion criteria
| Inclusion criteria |
| Workers exposed to high-power lines for more than 20 years |
| Reference groups were at same age range as exposed groups |
| Insignificantly exposed to electric field for reference groups |
| Male |
| Participants were living far from high-voltage power lines. |
| Willing to give informed consent |
| Willing to have dietary supplementation intake and underwent blood tests |
| Exclusive criteria |
| History of regular intake of green tea, vitamin C and vitamin E in the past year |
| Inheritance disorders in family |
| Body mass index (BMI) < 18.5 or > 30 kg/m2 |
| history long-term exposure to high-voltage power lines |
Figure 1Flow diagram of subjects screening
A total of 2456 subjects were enrolled in the current study. Workers exposed under 110–420 kV and the reference participants were treated with placebo or resveratrol.
Characteristics of subjects with no or long-term occupational exposure to extremely low electromagnetic field emitted from high voltage power lines
| Reference group ( | >20 years exposure ( | ||
|---|---|---|---|
| Age, years | 565±2 | 554 ± 6 | 0.162 |
| BMI, kg/m2 | 243 ± 1 | 242 ± 7 | 0.425 |
| Body temperature | 36 ± 41 ± 7 | 36 ± 62 ± 3 | 0.299 |
| Self-reported physical exercise, hours | 96 ± 1 | 95 ± 7 | 0.865 |
| Occupational exposure, h/day | - | 61 ± 2 | - |
| Mobile phone usage (hr/week) | 31 ± 8 | 31 ± 2 | 0.223 |
| Computer usage (hr/week) | 204 ± 6 | 213 ± 9 | 0.624 |
| Chronic diseases in 5 years (%) | 20 ± 1% | 23 ± 4%* | 0.021 |
| Health complaints (pain, headache, depression) (%) | 24 ± 5% | 30 ± 7%* | 0.012 |
Data are presented as mean ± SD, *p value < 0.05.
Levels of biomarkers of oxidative stress in workers exposed to high-voltage power lines and control group before and after resveratrol supplementation
| Reference group ( | > 20 years exposure ( | F | ||
|---|---|---|---|---|
| Before resveratrol supplementation | ||||
| Biomarkers of oxidative stress | ||||
| 8-OHdG (mg/mmol creatinine) | 25 ± 310.2 | 29 ± 87.5** | 11.881 | 0.01 |
| F2-isoprostane (ng/mg creatinine) | 14 ± 77.7 | 20 ± 46.4*** | 30.332 | < 0.001 |
| Serum melatonin (pg/ml) | 19 ± 68.5 | 20 ± 10.5 | 0.181 | 0.671 |
| Serum HSP70 (ng/L) | 1.4 ± 0.5 | 1.5 ± 0.5 | 1.857 | 0.175 |
| After 12-month of resveratrol supplementation | ||||
| Biomarkers of oxidative stress | ||||
| 8-OHdG (mg/mmol creatinine) | 24.6 ± 9.9 | 28.0 ± 4.4**# | 9.421 | 0.002 |
| F2-isoprostane (ng/mg creatinine) | 15.2 ± 8.3 | 18.4 ± 7.2**# | 7.923 | 0.005 |
| Serum melatonin (pg/ml) | 19.0 ± 11.8 | 19.6 ± 9.8 | 0.144 | 0.706 |
| Serum HSP70 (ng/L) | 1.2 ± 0.8 | 1.2 ± 0.7 | - | NS |
Data are presented as mean ± SD. *, ** or *** represent the comparison between exposed workers and reference group while # or ## represents the comparison between the individuals before and after supplementation. * and #p value < 0.05; ** and ##p value < 0.01; ***p value < 0.001; NS, non-significant.
8-OHdG, 8-hydroxy-2-deoxy-guanosine.
NF-κB, nuclear factor kappa B.
TNF-α, tumour necrosis factor-alpha.
HRC, high-sensitive C-reactive protein.
IL, interleukin.
Plasma levels of inflammatory biomarkers and ex vivo stimulation of cytokine production in workers exposed to high-voltage power lines and control group before and after resveratrol supplementation
| Reference group ( | > 20 years exposure ( | F | ||
|---|---|---|---|---|
| Before resveratrol supplementation | ||||
| Inflammatory biomarkers in plasma | ||||
| NF-κB, ng/L | 1038 ± 60.2 | 1020 ± 57.5* | 4.35 | 0.038 |
| HRP mg/L | 0.7 ± 0.7 | 0. 7 ± 0.9 | - | NS |
| IL-6 (pg/mL) | 1.1 ± 1.0 | 0.8 ± 0.6* | 6.271 | 0.013 |
| TNF-α ng/ml | 56.3 ± 9.2 | 52.7 ± 11.1* | 5.744 | 0.018 |
| IL-6 ng/ml | 72.2 ± 2.5 | 63.8 ± 23.3** | 6.991 | 0.009 |
| IL-1β ng/ml | 33.1 ± 1.2 | 29.2 ± 2.6* | 5.201 | 0.024 |
| IL-8 ng/ml | 4.4 ± 2.3 | 4.1 ± 2.6 | 0.679 | 0.407 |
| After 12-month of resveratrol supplementation | ||||
| Inflammatory biomarkers in plasma | ||||
| NF-κB, ng/L | 1043 ± 55.2 | 1041 ± 54.5# | 0.061 | 0.804 |
| HRP mg/L | 0.7 ± 1.2 | 0. 76 ± 1.2 | 0.119 | 0.734 |
| IL-6 (pg/mL) | 1.0 ± 0.8 | 1.11.5## | 0.314 | 0.576 |
| TNF-α ng/ml | 57.5 ± 14.9 | 55.7 ± 17.1# | 0.581 | 0.447 |
| IL-6 ng/ml | 69.8 ± 19.8 | 67.5 ± 21.6## | 0.570 | 0.451 |
| IL-1β ng/ml | 35.1 ± 16.4 | 33.9 ± 12.6## | 0.316 | 0.575 |
| IL-8 ng/ml | 4.2 ± 2.0 | 4.3 ± 2.2# | 0.105 | 0.747 |
Data are presented as mean ± SD. * or ** represent the comparison between exposed workers and reference group while # or ## represents the comparison between the individuals before and after supplementation. * and #p value < 0.05; ** and ##p value < 0.01; NS, non-significant.
8-OHdG, 8-hydroxy-2-deoxy-guanosine.
NF-κB, nuclear factor kappa B.
TNF-α, tumour necrosis factor-alpha.
HRC, high-sensitive C-reactive protein.
IL, interleukin.